RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+5.51%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$558M
AUM Growth
+$558M
(+29%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
20.56%
Top 10 Holdings %
Top 10 Hldgs %
37.3%
Holding
93
New
18
Increased
51
Reduced
4
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$27.5M |
| 2 |
Medtronic
MDT
|
$26.5M |
| 3 |
Cigna
CI
|
$8.74M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$8.09M |
| 5 |
AET
Aetna Inc
AET
|
$7.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$24.6M |
| 2 |
UnitedHealth
UNH
|
$14.8M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$11.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$9.64M |
| 5 |
AbbVie
ABBV
|
$4.8M |
Sector Composition
| 1 | Healthcare | 75.87% |
| 2 | Industrials | 2.28% |
| 3 | Financials | 1.34% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $28.2M | 5.05% | 340,000 +9,000 | +3% | +$746K |
|
|
2
Merck
MRK
$210B
| $27.5M | 4.93% | +475,000 | New | +$27.5M |
|
|
3
Medtronic
MDT
$119B
| $26.5M | 4.74% | +415,000 | New | +$26.5M |
|
|
ITMN
4
DELISTED
INTERMUNE INC
ITMN
| $23.8M | 4.26% | 538,000 +128,000 | +31% | +$5.65M |
|
5
McKesson
MCK
$85.4B
| $22.2M | 3.97% | 119,000 +27,500 | +30% | +$5.12M |
|
6
Biogen
BIIB
$19.4B
| $18.9M | 3.39% | 60,000 +4,750 | +9% | +$1.5M |
|
|
THOR
7
DELISTED
THORATEC CORPORATION
THOR
| $17.2M | 3.08% | 492,200 +91,200 | +23% | +$3.18M |
|
|
8
AbbVie
ABBV
$372B
| $15.5M | 2.78% | 275,000 -85,000 | -24% | -$4.8M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $14.7M | 2.63% | 65,750 +9,500 | +17% | +$2.12M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $13.7M | 2.46% | 160,000 +83,000 | +108% | +$7.13M |
|
11
Amgen
AMGN
$155B
| $13.6M | 2.44% | 115,000 | – | – |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $13.4M | 2.4% | 85,750 +37,250 | +77% | +$5.82M |
|
13
Thermo Fisher Scientific
TMO
$186B
| $12.7M | 2.29% | 108,000 +750 | +0.7% | +$88.5K |
|
|
AVDL
14
Avadel Pharmaceuticals
AVDL
$1.43B
| $11.6M | 2.08% | 775,000 +25,000 | +3% | +$375K |
|
15
Humana
HUM
$36.5B
| $9.26M | 1.66% | 72,500 +7,000 | +11% | +$894K |
|
16
CVS Health
CVS
$92.8B
| $9.14M | 1.64% | 121,250 +8,250 | +7% | +$622K |
|
|
17
Cigna
CI
$80.3B
| $8.74M | 1.57% | +95,000 | New | +$8.74M |
|
18
Intuitive Surgical
ISRG
$170B
| $8.67M | 1.55% | 21,050 +2,550 | +14% | +$1.05M |
|
19
Cooper Companies
COO
$13.4B
| $8.54M | 1.53% | 63,000 +2,500 | +4% | +$339K |
|
|
HRC
20
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.09M | 1.45% | +195,000 | New | +$8.09M |
|
|
ATHN
21
DELISTED
Athenahealth, Inc.
ATHN
| $7.79M | 1.4% | 62,250 +42,750 | +219% | +$5.35M |
|
22
Illumina
ILMN
$15.8B
| $7.68M | 1.38% | 43,000 +500 | +1% | +$89.3K |
|
|
SRGA
23
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $7.61M | 1.37% | 1,750,000 +1,063,618 | +155% | +$4.63M |
|
|
AET
24
DELISTED
Aetna Inc
AET
| $7.5M | 1.34% | +92,500 | New | +$7.5M |
|
25
Pacira BioSciences
PCRX
$1.2B
| $7.14M | 1.28% | 77,750 +16,750 | +27% | +$1.54M |
|